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Abstract We have identified several cDNAs for the human
Kir5.1 subunit of inwardly rectifying K+ channels. Alternative
splicing of exon 3 and the usage of two alternative polyadenyl-
ation sites contribute to cDNA diversity. The hKir5.1 gene
KCNJ16 is assigned to chromosomal region 17q23.1^24.2, and is
separated by only 34 kb from the hKir2.1 gene (KCNJ2). In the
brain, Kir5.1 mRNA is restricted to the evolutionary older parts
of the hindbrain, midbrain and diencephalon and overlaps with
Kir2.1 in the superior/inferior colliculus and the pontine region.
In the kidney Kir5.1 and Kir2.1 are colocalized in the proximal
tubule. When expressed in Xenopus oocytes, Kir5.1 is efficiently
targeted to the cell surface and forms electrically silent channels
together with Kir2.1, thus negatively controlling Kir2.1 channel
activity in native cells. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The family of inwardly rectifying potassium (Kir) channels
comprises several well-de¢ned subfamilies, e.g. weakly rectify-
ing Kir1/Kir4 channels, strongly voltage-dependent Kir2
channels, G protein-gated Kir3 channels and ATP/MgADP-
controlled Kir6 channels [1]. Primarily based on signi¢cant
structural di¡erences, two further subunits, Kir5.1 and
Kir7.1, were grouped separately. Kir7.1 subunits present in
the epithelia of several central and peripheral tissues have
now been recognized to form Kir channels with a non-con-
served pore region that results in unique unitary and macro-
scopic permeation and recti¢cation properties [2^6]. Yet,
much less is known about the function of Kir5.1 subunits,
which have been found by reverse transcription (RT)-PCR
in the adrenal gland, spleen, liver, kidney, testis, and brain
[7,8]. First attempts to express Kir5.1 in heterologous expres-
sion systems failed to generate K currents [7]. Coexpression
studies, however, demonstrated that Kir5.1 subunits as-
sembled into functional heteromeric complexes together with
Kir4.1/1.2 [9] and Kir4.2/1.3 subunits [10].
Here we report novel cDNA sequences for the rat (rKir5.1)
and human Kir5.1 (hKir5.1) subunits as well as the complete
genomic structure of the hKir5.1 gene KCNJ16. Based on the
¢nding that KCNJ16 is colocalized with the Kir2.1 gene
(KCNJ2) on chromosomal region 17q23.1^24.2 we investigate
a putative functional linkage between Kir5.1 and Kir2.1 sub-
units in mammalian tissues.
2. Materials and methods
2.1. Database and sequence analysis
The complete human gene encoding the Kir5.1 subunit KCNJ16
was identi¢ed from a large genomic GenBank database entry of chro-
mosome 17 (GenBank accession number AC005208) using the
BLAST algorithm [11] and the originally published cDNA sequence
of rKir5.1 (X83581). To obtain cDNA information, EST databases
were analyzed and several partial but overlapping IMAGE-EST
clones encoding hKir5.1 were obtained from the Resource Center of
the German Human Genome Project (RZPD) at the Max-Planck-In-
stitute for Molecular Genetics, Berlin, Germany, and completely se-
quenced.
2.2. RT-PCR analysis
To assay alternative splicing events in the 5P untranslated region
(UTR) of hKir5.1, human kidney RNA was reverse-transcribed using
Superscript II reverse transcriptase (Gibco BRL) and used as template
for RT-PCR. For RT-PCR analysis of human renal tissue fractions,
dissected tubules of 200 mm in total length and 400 glomeruli were
lysed in 4 M guanidinium bu¡er and total RNA was isolated using
the RNeasy kit (Qiagen, Hilden, Germany). After DNaseI (Promega,
Heidelberg, Germany) digestion RNA was reverse-transcribed using
MMLV reverse transcriptase (Promega). Ampli¢cations were per-
formed using intron-spanning primers localized on exons 2 and 4 of
Kir5.1 (132 bp), and on exons 1 and 2 for Kir2.1 (199 bp), respectively
(Kir5.1: 5P-AGGATTCTAACTGGCAGACTGG-3P ; 5P-GATTTCC-
CAGCTCAAGTCAAAG-3P, Kir2.1: 5P-TCTTGGGAATTCTGGT-
TTGC-3P ; 5P-TGGGAGCCTTGTGGTTCTAC-3P), with 94‡C dena-
turation, 52‡C annealing and 72‡C elongation (30 s each) for 35 cycles
using AmpliTaq Gold Polymerase (Perkin Elmer, Weiterstadt, Ger-
many). All PCR products were directly sequenced to con¢rm correct
ampli¢cation. As described before in detail [12] GAPDH-speci¢c
PCRs were performed as positive controls with reverse transcriptase
reactions from all nephron segments. As negative controls reverse
transcriptase was omitted. To exclude contaminations, appropriate
water controls excluding cDNAs were additionally performed.
2.3. Chromosomal assignment of KCNJ16
The exact position of KCNJ16 on chromosome 17 was identi¢ed
using a 339 bp PCR fragment (containing exon 2) which was ampli-
¢ed from a Stanford TNG4 radiation hybrid panel [13] using the
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following ampli¢cation primers: FOR: 5P-AGCAGCTCCACATA-
GAAAAAGC-3P, BACK: 5P-TAACACTTTCAAAAAAGCCACG-
3P. The resulting data vector was analyzed using RH mapping at
the Stanford Human Genome Center (http://www-shgc.stanford.edu/
Mapping/rh/index.html), the GeneMap 99 at the National Center for
Biotechnology Information (http://www.ncbi.nlm.nih.gov/genemap)
and the Genome Database (http://www.gdb.org).
2.4. In situ hybridization of Kir5.1 in rat brain
In situ hybridizations with Kir5.1 probes and all appropriate
controls were performed on 16 Wm cryostat brain sections of adult
Wistar rats as described in detail elsewhere [14]. Here, synthetic anti-
sense oligonucleotides were chosen from both the UTR and open
reading frame (ORF) of rKir5.1 [7] with least tendency of forming
hairpins and self-dimers (coding strand positions indicated): 5PUTR:
5P-350CGTGCTTGCAGCTCAGGGCCTTCAGGTAAGGGTCAG-
AGAGGAGGG31-3P and ORF: 5P-1254CTGGGATTCCATGGAGA-
TCCTGTTTAAAGTCAGGAGGGC1216-3P. Parallel sections were
hybridized to oligonucleotide probes speci¢c for Kir2.1 as previously
published [14]. In brief, oligonucleotides were 3P end-labeled with
[35S]dATP or [33P]dATP (New England Nuclear, Boston, MA,
USA; 1200 and 1000 Ci/mmol) by terminal deoxynucleotidyl trans-
ferase (Roche Diagnostics, Mannheim, Germany) and used for hy-
bridization at concentrations of 2^10 pg/Wl (4W105 cpm/100 Wl hybrid-
ization bu¡er per slide). Slides were air-dried and hybridized for 20^24
h at 43‡C in 100 Wl bu¡er containing 50% formamide, 10% dextran
sulfate, 50 mM dithiothreitol, 0.3 M NaCl, 30 mM Tris^HCl, 4 mM
EDTA, 1UDenhardt’s solution, 0.5 mg/ml denatured salmon sperm
DNA, and 0.5 mg/ml polyadenylic acid and labeled oligonucleotide
probe. Sections were washed 2U30 min in 1USSC plus 50 mM L-
mercaptoethanol, 1 h in 1USSC at 60‡C, and 10 min in 0.1USSC at
room temperature. Specimens were then dehydrated, air-dried and
exposed to Kodak BIOMAX X-ray ¢lm for 16^28 days. For cellular
resolution, selected slides were dipped in photographic emulsion Ko-
dak NTB2, incubated for 8^16 weeks and then developed in Kodak
D-19 for 2.5 min. For identi¢cation of brain structures with bright-
and dark-¢eld optics, sections were Nissl-counterstained with cresyl
violet [15].
2.5. Construction of Kir5.1 expression vectors
For expression, the coding regions of rKir5.1 and hKir5.1 were
PCR-ampli¢ed using primers containing start and stop codons, re-
spectively (hKir5.1-FOR: 5P-AGAATGAGCTATTACGGCAGCA-
GC-3P ; hKir5.1-BACK: 5P-CAGTGGTAGCCCTCATAATTGC-3P ;
rKir5.1-FOR: 5P-ATGAGCTATTACGGAAGTAGC-3P ; rKir5.1-
BACK: 5P-CTACATCTGGGATTCCATGGA-3P). The PCR pro¢le
was 94‡C, 52‡C (30 s each), 72‡C (2 min) for 30 cycles using Ampli-
Taq Gold Polymerase (Perkin Elmer). PCR products were sequenced
and blunt-end ligated into the Xenopus expression vector pSGEM (a
gift of Dr. M. Hollmann, Go«ttingen, Germany). In addition, hKir2.1
and hKir5.1 cDNAs were fused to the gene encoding the enhanced
green £uorescence protein (EGFP) in pEGFP-C1 (Clontech) and then
subcloned into pSGEM.
2.6. Electrophysiological analysis
For expression in Xenopus laevis oocytes capped run-o¡ poly(A)
cRNA transcripts were synthesized from wild-type and mutant Kir5.1,
Kir2.1, and Kir2.1^Kir5.1 concatemers, and injected individually (V3
ng each) or in combination (with Kir2.1 cRNA held constant) in
defolliculated oocytes. Oocytes were incubated at 19‡C in ND96 so-
lution (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 5 mM
HEPES, pH 7.4^7.5), supplemented with 100 Wg/ml gentamicin and
2.5 mM sodium pyruvate, and assayed 48 h after injection. Two-elec-
trode voltage-clamp measurements were performed with a Turbo Tec-
10 C ampli¢er (npi, Tamm, Germany) and sampled through an EPC9
(Heka Electronics, Lambrecht, Germany) interface using Pulse/Pulse-
¢t software (Heka). Oocytes were placed in a small-volume perfusion
chamber and bathed with ND96 or ‘high K’ solution (96 mM KCl,
2 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 5 mM HEPES, pH 7.4^7.5).
For cell-attached single-channel recordings patch pipettes were
pulled from borosilicate glass capillaries (Hilgenberg, Malsfeld, Ger-
many), Sylgardz-coated (Dow Corning, USA), and heat-polished to
give input resistances of 1^2 M6. The pipette recording solution con-
tained 120 mM KCl, 10 mM HEPES, and 1.8 mM CaCl2 (pH 7.3),
and the bath solution was changed to 120 mM KCl, 10 mM HEPES,
10 mM EGTA, 2.4 mM MgCl2, 1.13 mM Na2ATP. Using Pulse/
Pulse¢t currents were recorded in voltage-clamp with an EPC9 patch
clamp ampli¢er (Heka) and low pass-¢ltered at 1^2 kHz.
3. Results
3.1. Cloning of hKir5.1
A GenBank database homology search with rKir5.1 identi-
¢ed a large genomic database entry of chromosome 17 har-
boring KCNJ16. Based on this sequence information two
overlapping cDNA clones encoding hKir5.1 were retrieved
from an EST database and assembled into a 2089 bp long
cDNA clone including a polyadenylation signal (AATAAA)
preceding the poly(A) stretch (Fig. 1). The resulting ORF
encodes a protein of 418 amino acids which is 34 amino acids
longer than the Kir5.1 sequence originally identi¢ed from rat
brain [7]. Since we ampli¢ed ORFs of 1254 bp from both rat
and human templates we interpret the cDNA sequence de-
scribed by Bond et al. [7] to be truncated, possibly due to a
frameshift error at residue 351. At the amino acid level,
hKir5.1 is 91% identical to both rKir5.1 and the recently
published mouse Kir5.1 [16]. Based on the novel sequences,
Kir5.1 now appears most closely related to members of the
Kir2 family, with 43% (56% nucleotide similarity) identity to
Kir2.1 [17], 42% (53%) identity to Kir2.2 [18], 41% (55%)
identity to Kir2.3 [19] and 40% (51%) identity to Kir2.4 [20].
3.2. Genomic structure of KCNJ16
Analysis of the genomic structure of KCNJ16 and compar-
ison to an EST clone from a parathyroid tumor database
revealed that the terminal 5PUTR of the cDNA is encoded
by four small exons of 106 bp (exon 1), 109 bp (exon 2), 81 bp
(exon 3) and 97 bp (exon 4). The ¢fth exon is much larger
(1681 bp) and harbors the remaining 5PUTR, the entire cod-
ing region and the complete 3PUTR (Fig. 2). Direct sequenc-
ing of the exon^intron boundaries showed that donor and
acceptor splice sites are conserved in all cases (GT/AG; Fig.
2B).
The sequences of intron 1 (25 267 bp), intron 2 (7534 bp),
intron 3 (22 497 bp), and intron 4 (1019 bp) show multiple
repetitive elements. Within intron 2, exon 3 appears to be
duplicated approximately 1.6 kb upstream (Fig. 2). The puta-
tive exon 3b is 90% identical to exon 3, and has conserved 5P
and 3P splice sites, however, it has not been found in any EST
clone or PCR ampli¢cation product of various tissues. More-
over, when the stretch around exon 3 was analyzed by RT-
PCR from human kidney RNA, neither exon 3 nor 3b was
found in the cDNA. Thus, in kidney, a tissue-speci¢c splicing
mechanism results in a shorter hKir5.1 variant of 1856 bp
(Fig. 2).
An alternative polyadenylation event was detected in sev-
eral partial hKir5.1 clones from parathyroid tumor, kidney,
brain and thyroid cDNA libraries (Fig. 2). In this case V2 kb
are added to the 3P end beyond the ¢rst polyadenylation sig-
nal resulting in a hKir5.1 cDNA of 4021 bp.
3.3. hKir2.1 cDNA and gene structure
Remarkably, another overlapping DNA fragment from
chromosome 17 was found to contain KCNJ2, the gene that
encodes the hKir2.1 subunit (Fig. 2). Sequence comparison of
KCNJ2 with the hKir2.1 cDNA [16] revealed that the 5PUTR
is split by a single intron (4311 bp) with several repetitive
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elements. In KCNJ2, exon 1 (166 bp) is preceded by a region
homologous to the rat KCNJ2 promotor region [21], and exon
2 (5220 bp) contains the remaining 5PUTR, the coding region
(which is 98% identical to the rat and mouse sequence), and
the 3PUTR with the polyadenylation signal, predicting a total
cDNA sequence ofV5.4 kb. Between the end of KCNJ16 and
the transcriptional start site of KCNJ2 (deduced by homology
to the mouse Kir2.1 [16]) there are only 34 kb, indicating an
ancient gene duplication event in evolution.
3.4. Assignment to chromosomal region 17q23.1^24.2
To identify the exact chromosomal position of hKir5.1, the
Stanford radiation hybrid panel [13] was analyzed. KCNJ16
was mapped to chromosome 17, 53 cR50000 from the £anking
markers SHGC-78842 and 74 cR50000 from SHGC-79125 (Ta-
ble 1). Electronic PCR places these markers proximal and
distal of the Kir2.1 and Kir5.1 loci within BAC clones
AC005242 and AC004562, respectively. These clones are
part of contig NT-001524 which can be placed on the Gene-
Map 99 physically to the interval D17S795^D17S840, 90.2^
94.8 cM from the pter of chromosome 17, by microsatellite
marker D17S1786 (AFMa112yb5) and the gene marker map
kinase 6 (MAP2K6). According to the Genome Database this
interval corresponds to the cytogenetic map in the region
17q23.1^17q24.2.
3.5. Distribution of Kir5.1 in the rat brain
To date, the cellular distribution pattern of Kir5.1 in mam-
Fig. 1. cDNA sequence of the hKir5.1/KCNJ16 gene. The full-length sequence is assembled from two EST clones (AA846603, AI271845) and
has been submitted to GenBank under the accession number AF153815. The ORF encodes a protein with 418 amino acids with two predicted
transmembrane regions (M1, M2; boxed in black) and a pore-forming structure (P1; boxed in gray). Amino acid sequence is shown in the sin-
gle-letter code. Note that the hKir5.1 sequence is extended by 34 amino acids compared to rKir5.1 sequence published originally.
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malian brain has not been analyzed. Because of the close
proximity of Kir5.1 and Kir2.1 we were interested in compar-
ing their localization in the rat brain by in situ hybridization.
Analysis of the hybridization signals in sagittal and coronal
sections showed that expression of Kir5.1 was restricted to the
more ancient parts of the brain: hindbrain, midbrain and
diencephalon (Fig. 3). In this respect Kir5.1 di¡ers from all
other Kir channels localized in the brain so far. The strong
and homogenous Kir5.1 expression indicates expression both
in neurons and glia. Whereas at high resolution no signal was
found in oligodendrocytes, small-size astrocytes were clearly
labeled, for example in the facial nucleus and other nuclei
containing large motoneurons but no small interneurons, or
at the border of the molecular and Purkinje cell layer of the
cerebellum. Further non-neuronal structures such as the epen-
dymal layers lining the ventricles were also found positive.
In contrast, the complete cerebral hemisphere including the
cortex, hippocampal formation, basal ganglia and amygdala
was largely unlabeled. Notable exceptions were moderate sig-
nals in a population of layer V neurons in the forelimb and
hindlimb of the cortex and the retrosplenial cortex, as well as
in the hippocampal CA1 and dentate gyrus granule cell layer.
In situ hybridization analysis with Kir2.1-speci¢c probes
performed here and in an earlier study [14] demonstrated
that Kir2.1 coexpresses with Kir5.1 at some distinct sites in
the anterior pretectal nucleus, in the superior and inferior
colliculus, and in the pontine nucleus (e.g. Fig. 3D).
3.6. Distribution of Kir5.1 and Kir2.1 in the human kidney
When assayed by RT-PCR, hKir5.1 expression was found
in the proximal tubule, the thick ascending limb and the cor-
tical collecting duct of human kidney (Fig. 4), but was absent
from isolated glomeruli. On the other hand, Kir2.1 signals
were only detected in isolated glomeruli and in the proximal
tubule system (Fig. 4). Thus, in human kidney both subunits
are coexpressed only in the proximal part of the tubule sys-
tem, as shown in the diagram (Fig. 4B).
3.7. Functional expression of hKir5.1
Previous studies in Xenopus oocytes have documented that
rKir5.1 fails to form functional homomeric channels, but re-
quires speci¢c coassembly with Kir4.1/Kir4.2 subunits [7,9].
One possible explanation for the lack of functional expression
of Kir5.1 is that a retention signal prevented the targeting to
the surface membrane (analogous to the retention signal
(RKR) recently detected in the C-terminus of Kir6 subunits
[22^24]). Indeed, we identi¢ed two putative retention signals
at positions 317 (KRK) and 370 (RRR) in the hKir5.1 C-
terminus, respectively. However, when these sites were re-
placed by glycine residues, individually or in combination,
the modi¢ed hKir5.1 subunits still failed to express functional
channels in oocytes (n = 10 each).
In another set of experiments we tagged hKir5.1 with
EGFP at the NH2-terminus to investigate its subcellular local-
ization. cRNAs of EGFP-hKir5.1 and EGFP-Kir2.1 were in-
jected into oocytes and membrane £uorescence was studied by
confocal microscopy. After 48 h we found strong membrane
£uorescence (quanti¢ed by line-scan luminometry) which was
indistinguishable for injection of Kir2.1, Kir5.1 or a 1:1 com-
bination of both (Fig. 5B, inset). Despite their obvious local-
Fig. 2. Genomic organization of the human KCNJ16/KCNJ2 gene cluster located on chromosome 17q23.1^24.3. (A) KCNJ16 is V60 kb in
length and contains ¢ve (+one putative) exons (GenBank accession numbers AF153809^AF153814), KCNJ2 is V10 kb in length and consists
of two exons (GenBank accession numbers AF1538218^AF1538220). Coding regions are shown as black boxes, non-coding regions as white
boxes, the putative exon 3b of KCNJ16 is denoted. For clarity intronic sequences (taken from genomic GenBank entries AC005208 and
AC005242) have been reduced 10-fold compared to exon size. Note that exon 5 of KCNJ16 is only 34 kb upstream of the KCNJ2 transcrip-
tional start site. Positions of polyadenylation sites and putative promotor regions are indicated by arrows.
Table 1
Stanford TNG4 panel radiation hybrid mapping data
Gene/locus Primer pair
(product size)
Data vectora Flanking
marker
Physical
distance
Lod score Cytogenetic
map location
GeneMap 99
interval
Kir5.1 Kir5.1ex2 for,
Kir5.1ex2 rev
000000001000000001010
000110100000011001100
001100000100001001110
000000011100000000000
010000
SHGC-78842 53 cR50000 6.34 17q23.1^
17q24.2
D17S795^
D17S840
SHGC-79125 74 cR50000 4.01
a0, negative; 1, positive.
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ization in the membrane hKir5.1 subunits fail to form func-
tional channels. Nevertheless, we obtained evidence for inter-
action of Kir5.1 subunits with Kir2.1, in contrast to previous
¢ndings [9]. When Kir2.1 and Kir5.1 cRNAs were injected at
equimolar amounts (ns 10), all macroscopic current proper-
ties were virtually indistinguishable from Kir2.1 currents, but
the current amplitude at 3100 mV was reduced to 63% (from
322.7 þ 7.4 WA to 314.3 þ 2.2 WA). Injection of larger
amounts of Kir5.1 cRNA (with Kir2.1 cRNA kept constant)
further decreased the macroscopic current amplitude. At a
Kir5.1/Kir2.1 cRNA ratio of 2:1 Kir2.1 activity was sup-
pressed to 43% (39.5 þ 2.4 WA), at a Kir5.1/Kir2.1 ratio of
5:1 the current amplitude was reduced to 5% (30.09 þ 0.02
WA; n = 10 each; Fig. 5A,C). In contrast, no e¡ect was ob-
served on the macroscopic amplitudes of Kir1.1 (ROMK)
currents, when Kir5.1 cRNA was coinjected. Moreover, no
channel activity was detected in oocytes after injection of en-
gineered Kir2.1^Kir5.1 dimers. Additional evidence for a mo-
lecular interaction between the two subunit species was ob-
tained from experiments using mutant Kir5.1 subunits in
which the pore signature GYG was changed to VYG
(Kir5.1G133V) to further disturb channel function. When
Kir5.1G133V cRNA was coinjected with Kir2.1 at a 1:1 ratio
the macroscopic current amplitudes were only 39% of the
Kir2.1 control (white bar in Fig. 5), which is a statistically
signi¢cant reduction compared to wild-type Kir5.1 subunits
(Student’s t test ; P6 0.01). Single-channel cell-attached re-
cordings revealed that oocytes coinjected with Kir5.1 and
Kir2.1 at a 1:1 ratio exhibited only one additional single-
channel population with a unitary conductance typical of ho-
momeric Kir2.1 channels (Q= 27 pS; n = 15). In summary,
these data support the notion that Kir5.1 subunits coassemble
Fig. 3. In situ hybridization of Kir5.1 and Kir2.1 mRNAs in the rat brain. Sections were hybridized with 33P-labeled speci¢c oligonucleotides
as described in Section 2. X-ray ¢lm autoradiographs of a sagittal (A,B) and transversal sections (C^F) show Kir5.1 mRNA primarily restricted
to the midbrain, hindbrain and diencephalon (A,C,D,E), and strong coexpression of Kir2.1 mRNAs (F) in the pontine region (Pn). (B) No sig-
nal is present in a control section digested with RNase A prior to hybridization with Kir5.1-speci¢c probes. Exposure time was 26 days. Scale
bars represent 4 mm (A,B), 3 mm (C^F).
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with Kir2.1 to form electrically silent channels and thus func-
tion as negative regulators of the Kir2.1 conductance.
4. Discussion
Our ¢nding that in man the genes for Kir5.1 (KCNJ16) and
Kir2.1 (KCNJ2) are colocalized on chromosome 17q in close
proximity is paralleled in the mouse where Kir5.1 [16] and
Kir2.1 [25] have been mapped to the distal region of chromo-
some 11 (also found on the single unmapped mouse genomic
database entry AC025586), which shares homology with hu-
man chromosome 17q. Thus, the chromosomal association of
Kir5.1 and Kir2.1 is similar to other pairs of Kir subunits that
in humans are colocalized on the same chromosomal arm and
may be an indication for an early gene duplication event [26].
The high similarity in primary sequence and functional prop-
erties of subunits within the subfamilies suggest that an an-
cient intrachromosomal gene duplication event separating two
members of the Kir family has taken place prior to copying
these pairs to di¡erent chromosomal locations, thereby form-
ing Kir subfamilies. The lower homology between Kir2.1 and
Kir5.1 (43% and 56% identity at the amino acid and nucleo-
Fig. 4. Expression of hKir5.1 and hKir2.1 subunits in human kidney. (A) RT-PCR analysis of human glomeruli (GLO), proximal tubules (PT),
thick ascending limbs (TAL), and cortical collecting ducts (CD). Also shown is a molecular weight marker (left lane). White arrows denote the
size of correct PCR fragments. As shown in the bottom panel all RT samples were positive for GAPDH, indicating integrity of isolated RNAs
and successful reverse transcription. Negative controls were performed with all RNA samples to exclude contaminations. (B) Schematic diagram
of hKir5.1 and hKir2.1 expressed in the di¡erent segments of the nephron.
Fig. 5. Coexpression of hKir5.1 and Kir2.1 subunits in Xenopus oocytes. (A) Ramp recordings (2 s) from Xenopus oocytes injected with Kir2.1
cRNA individually, or in combination with hKir5.1 cRNA at the ratios indicated (with constant amounts of Kir2.1 cRNA). (B) Confocal im-
ages of the membrane £uorescence of oocytes injected with EGFP-Kir2.1, EGFP-Kir5.1, EGFP-Kir2.1+Kir5.1, and water (control), respec-
tively. Laser-scan images were taken from the animal pole on an Axiovert 135 microscope equipped with an argon^crypton laser with a 16U
oil objective lens. (C) Bar graph showing the mean current amplitudes (n = 10) from oocytes injected with Kir2.1 alone and together with
Kir5.1 at the ratios indicated. The open bar is the result of Kir2.1 coinjected with mutant Kir5.1G133V subunits (asterisk denotes statistical
signi¢cance at the 0.01% level).
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tide level, respectively), compared to the homologies among
members of the same subfamily, may be the result of a long
independent evolutionary process following the ¢rst intrachro-
mosomal duplication.
In relation to the present study it is intriguing that the
hKir2.2 gene (KCNJ12) which is also located on chromosome
17 (17p11.1) has been copied to encode a protein hKir2.2v
(KCNJN1) which exhibits 95% amino acid similarity [27],
but represents a silent gene product when expressed by itself
and acts as a negative regulator of the hKir2.2 channel activ-
ity [28]. By analogy, we may speculate from the sequence
similarity that Kir5.1 is a doublet of Kir2.1 that has adopted
a similar modulatory function early in evolution.
In agreement with a recent immunochemical analysis with
Kir5.1-speci¢c antibodies [8], our confocal localization studies
in Xenopus oocytes with EGFP-tagged Kir5.1 indicate that
Kir5.1 subunits are normally synthesized and transported to
the surface membrane. When assembled with Kir4.1/4.2 sub-
units, Kir5.1 subunits form functional channels in a preferred
4-5-4-5 stoichiometry with altered gating kinetics, increased
macroscopic amplitude and single-channel conductance
[9,10]. Moreover, the activity of Kir4.1/5.1 channels is com-
pletely blocked by internal acidi¢cation 6 pH 7 which may
cause the channels to function as physiological pH sensors
[29,30]. Thus, both in peripheral tissues (e.g. kidney, liver,
spleen, adrenal gland and testis), and in the brain (where
both mRNA species appear to be colocalized in glial and ep-
ithelial cells [31]), Kir5.1 forms a conducting channel pore
when complexed together with Kir4.1 but suppresses the ac-
tivity of Kir2.1 channels. The microscopically identi¢ed local-
ization at the cell surface and our functional data suggest that
Kir5.1 subunits indeed incorporate into silent heteromeric
channel complexes together with Kir2.1, rather than suppress-
ing the expression and transport of Kir2.1 subunits by other
mechanisms. Thus, in native tissue where Kir5.1 is strongly
coexpressed with Kir2.1, for example, in the pontine region of
the brain or the proximal tubule of the kidney, it is quite
likely that Kir5.1 subunits act as a negative regulator of the
Kir2.1 conductance.
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